In addition, combining the programmed death-ligand 1 (PD-L1) antibody with Fe3O4@MIPs PTT could effectively inhibit not only the growth of primary tumors, but also tumor metastasis by eliciting immunological effects. Here, CD274 is linked to neoplasm.